Metformin is a token designed to support a significant research initiative led by a team of three experienced medical doctors. With a robust history of publications in high-impact medical journals, this project focuses on exploring the longevity benefits associated with metformin. Recognized primarily for its effectiveness in managing type 2 diabetes, metformin has garnered increasing attention for its potential effects on aging and chronic diseases. The token serves to facilitate research and development in this promising area of longevity science. Preclinical and clinical studies have indicated that metformin may influence various biological mechanisms related to aging. This research aims to unlock new possibilities in understanding how metformin can contribute to healthier aging and the management of age-related conditions. By investing in this token, stakeholders support the ongoing exploration of metformin's role in longevity, paving the way for innovative solutions in health and wellness. The initiative emphasizes a scientific approach, leveraging established medical expertise to drive advancements in the field. Overall, Metformin token embodies a commitment to enhancing human health through rigorous research and the potential application of findings in longevity science.